MetamucilTherapy for Regularity (The Procter & Gamble Manufacturing Company)
Welcome to the PulseAid listing for the Metamucil drug offered from The Procter & Gamble Manufacturing Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | The Procter & Gamble Manufacturing Company |
| NON-PROPRIETARY NAME: | Psyllium Husk |
| SUBSTANCE NAME: | PSYLLIUM HUSK |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 1989-03-31 |
| END MARKETING DATE: | 0000-00-00 |
Metamucil Therapy for Regularity HUMAN OTC DRUG Details:
| Item Description | Metamucil Therapy for Regularity from The Procter & Gamble Manufacturing Company |
| LABELER NAME: | The Procter & Gamble Manufacturing Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.4(g/12g) |
| START MARKETING DATE: | 1989-03-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 37000-023_8d0bdf7b-6d73-4f5f-b824-326ed15b212e |
| PRODUCT NDC: | 37000-023 |
| APPLICATION NUMBER: | part334 |
Other PSYLLIUM HUSK Pharmaceutical Manufacturers / Labelers:
